Original article—liver, pancreas, and biliary tract
Predicting Early Mortality After Acute Variceal Hemorrhage Based on Classification and Regression Tree Analysis

https://doi.org/10.1016/j.cgh.2009.08.011Get rights and content

Background & Aims

Available prognostic models for mortality after an acute variceal hemorrhage have limitations that restrict their clinical value. We assessed the performance of a novel prognostic approach based on classification and regression tree (CART) analysis.

Methods

Logistic regression (LR) and CART analyses were performed to identify prognostic models for mortality at 6 weeks in a single-center cohort of 267 consecutive patients with acute variceal bleeding. Receiver operating characteristic (ROC) curves were constructed to assess the performance of the models. Prognostic models were fitted and validated by split-sample technique (training set, 164 patients, 2001–2005; test set, 103 patients, 2006–2008).

Results

After 6 weeks, 21% of patients experienced rebleeding and 24% died. The best LR model was based on Child–Pugh score, creatinine level, bacterial infection, and hepatocellular carcinoma. CART analysis provided a simple algorithm based on the combined use of just 3 variables (Child–Pugh score, creatinine level, and bacterial infection), allowing accurate early discrimination of 3 distinct prognostic subgroups with 8% (low risk), 17% (intermediate), and 50% to 73% (high) mortality. Its accuracy was similar to the LR model (area under the ROC curves, 0.81 vs 0.84; P = .17) and better than that of Child–Pugh (0.75; P = .05) and model for end-stage liver disease (0.74; P = .05). The prognostic accuracy of both LR and CART models was validated in the test set (area under the ROC curve values, 0.81 and 0.83, respectively).

Conclusions

A simple CART algorithm based on Child–Pugh score, creatinine level, and infection allowed an accurate predictive assessment of 6-week mortality after acute variceal bleeding.

Section snippets

Patients

All consecutive episodes of esophageal variceal bleeding in patients with cirrhosis admitted to the Bleeding Unit of our hospital were registered prospectively and included in the study from January 2001 to December 2008. Patients bleeding from gastric varices (n = 26) or portal gastropathy (n = 39) were not included in the study because of their different natural history and prognosis. Baseline and follow-up clinical, biochemical, and radiologic characteristics were recorded. The protocol was

Patient Features and Treatment

During the 8-year period of analysis, 267 consecutive patients with esophageal variceal bleeding admitted to the Bleeding Unit of our hospital were registered. Basal clinical characteristics at admission of patients in the training and test sets are shown in Table 1. Among the 229 patients who underwent an endoscopic treatment, 101 received EST and 128 received EVL. Surgical shunting was performed in 3 patients (2 early rebleeding, 1 for prophylaxis) and 10 patients were treated with

Discussion

In the present study we propose and validate a novel prognostic approach based on CART analysis to assess 6-week mortality in a cohort of patients after an acute esophageal variceal hemorrhage. Clinical outcomes of a large single-center cohort in a day-to-day clinical setting also are described.

The results clearly confirm an improvement in the outcomes of patients with acute variceal bleeding in the past few years compared with historical cohorts. The 24% mortality rate in our study (21%

References (30)

  • R. De Franchis

    Evolving consensus in portal hypertensionReport of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

    J Hepatol

    (2005)
  • P. Gines et al.

    Compensated cirrhosis: natural history and prognosis

    Hepatology

    (1987)
  • P.A. McCormick et al.

    Improving prognosis following a first variceal hemorrhage over four decades

    Gut

    (2001)
  • N. Carbonell et al.

    Improved survival after variceal bleeding in patients with cirrhosis over the past two decades

    Hepatology

    (2004)
  • K. Bambha et al.

    Predictors of early re-bleeding and mortality after acute variceal hemorrhage in patients with cirrhosis

    Gut

    (2008)
  • Cited by (125)

    • Intensive Care Unit Care of a Patient with Cirrhosis

      2023, Medical Clinics of North America
    • Endoscopic Treatment of Portal Hypertension and Its Complications

      2022, Techniques and Innovations in Gastrointestinal Endoscopy
    • Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?

      2021, European Journal of Internal Medicine
      Citation Excerpt :

      Variceal bleeding is a severe cirrhosis-related complication. The 6-week mortality in patients with decompensated cirrhosis is in the range of 10–25%, while mortality in patients with compensated cirrhosis is low [5,72,74,75]. Multiple randomized clinical trials have assessed the clinical efficacy of primary bleeding prophylaxis in patients with high-risk GEV.

    • Treatment of Acute Variceal Bleeding in 2021—When to Use Transjugular Intrahepatic Portosystemic Shunts?

      2021, Clinics in Liver Disease
      Citation Excerpt :

      The prognosis of AVB has improved significantly over the past decades due to better management of the hemorrhage and its associated complications. Mortality, however, still is approximately 15% to 20%.5,6 Moreover, variceal bleeding can trigger other complications of cirrhosis, such as bacterial infections, HE, and hepatorenal syndrome, that deteriorate prognosis further.

    View all citing articles on Scopus

    Conflicts of interest The authors disclose no conflicts.

    Funding Salvador Augustin is a recipient of a fellowship grant from the Institut de Recerca Vall d'Hebron/La Caixa, and is enrolled in the postgraduate program of the Universitat Autònoma de Barcelona; José Altamirano is a recipient of the fellowship grant Estímulo Héctor Orozco Zepeda 2007 from Fundación Mexicana para la Salud (FUNSALUD) AC and Fundación Mexicana para la Salud Hepática (FUNDHEPA) AC, Mexico.

    View this article's video abstract at www.cghjournal.org.

    View full text